Skip to main contentAll experts

Tarik Benidir

CLIN AST PROF

MD-UROLOGY

  • CLIN AST PROF
    MD-UROLOGY

GRANTS

  • GRANT
    A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Cg Oncology24 Jun 2025 - 23 Jun 2030
    Active
  • GRANT
    Salvage Focal Therapy via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer (FocalHIFU) (NCT06402357)
    Edap Technomed18 Nov 2024 - 17 Nov 2029
    Active